Name | Human HGF Quantikine SixPak (6 Plates) |
---|---|
Supplier | R&D Systems |
Catalog | SHG00 |
Category | ELISA Kit |
Assay Type | Solid Phase Sandwich ELISA |
Sample Type | Cell Culture Supernates (50 µL), Serum (50 µL), EDTA Plasma (50 µL), Citrate Plasma (50 µL) |
Sensitivity | 40 pg/mL |
Range | 125 - 8,000 pg/mL (Serum, Cell Culture Supernates, Citrate Plasma, EDTA Plasma) |
Format | 96-well strip plate |
Description | The Quantikine Human HGF Immunoassay is a 4.25 or 4.5 hour solid phase ELISA that is designed to measure HGF levels in cell culture supernates, serum, and plasma |
Gene | HGF |
Supplier Page | Shop |
Sakai K, Takeda M, Okamoto I, Nakagawa K, Nishio K. Oncol Lett. 2015 Jan;9(1):405-410. Epub 2014 Nov 11.
Necchi A, Pennati M, Zaffaroni N, Landoni E, Giannatempo P, Raggi D, Schwartz LH, Morosi C, Crippa F, Fare E, Nicolai N, Lanocita R, Sava T, Sacco C, Messina C, Ortega C, De Braud FG, Salvioni R, Daidone MG, Gianni AM, Mariani L. Br J Cancer. 2014 Jan 7;110(1):26-33.
Wertenbroek MW, Schepers M, Kamminga-Rasker HJ, Bottema JT, Muller Kobold AC, Roelofsen H, de Jong KP. BMC Cancer. 2013 May 30;13:266.
Kinzebach S, Dietz L, Kluter H, Thierse HJ, Bieback K. BMC Cell Biol. 2013 Oct 30;14:48.
Li Q, Zhang A, Tao C, Li X, Jin P. Biochem Biophys Res Commun. 2013 Nov 22;441(3):675-80. doi:
Conforti A, Biagini S, Del Bufalo F, Sirleto P, Angioni A, Starc N, Li Pira G, Moretta F, Proia A, Contoli B, Genovese S, Ciardi C, Avanzini MA, Rosti V, Lo-Coco F, Locatelli F, Bernardo ME. PLoS One. 2013 Nov 7;8(11):e76989.
Rittig K, Dolderer JH, Balletshofer B, Machann J, Schick F, Meile T, Kuper M, Stock UA, Staiger H, Machicao F, Schaller HE, Konigsrainer A, Haring HU, Siegel-Axel DI. Diabetologia. 2012 May;55(5):1514-25.
Llovet JM, Pena CE, Lathia CD, Shan M, Meinhardt G, Bruix J. Clin Cancer Res. 2012 Apr 15;18(8):2290-300.
Jaedicke KM, Taylor JJ, Preshaw PM. J Immunol Methods. 2012 Mar 30;377(1-2):62-5.
Patki S, Patki U, Patil R, Indumathi S, Kaingade P, Bulbule A, Nikam A, Pishte A. Cytokine. 2012 Aug;59(2):305-8.